A New Option for Some People With Lung Cancer: What the Approval of Lorlatinib Means for Patients

A New Option for Some People With Lung Cancer: What the Approval of Lorlatinib Means for Patients

The FDA recently approved the drug lorlatinib for the treatment of some non-small cell lung cancer. Doctors talk to SurvivorNet about the significance of this approval.

NOW
PLAYING
Understanding PI3K Inhibitors: How Can This Type of Targeted Therapy Treat CLL?
NOW
PLAYING
Changing the Way CLL is Treated: What are BTK Inhibitors?
NOW
PLAYING
Understanding BCL-2 Inhibitors: How Can This Targeted Therapy Treat CLL?
NOW
PLAYING
How Does Atezolizumab (Tecentriq) Treat Lung Cancer?
NOW
PLAYING
'I Have Some Swallowing Issues!' Fearless Kathy Griffin, 61, Makes Racy Joke About Her Sex Life After Cancer
NOW
PLAYING
How is Melanoma Treated After Surgery?

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.